Article
Phase-separation of EML4-ALK variant 3 is dependent upon an active ALK conformation
2020-06-11
Abstract excerpt
<h4>ABSTRACT</h4> Oncogenic fusions involving tyrosine kinases are common drivers of non-small cell lung cancer (NSCLC). There are at least 15 different variants of the EML4-ALK fusion, all of which have a similar portion of ALK that includes the kinase domain, but different portions of EML4. Targeted treatment with ALK tyrosine kinase inhibitors (TKIs) has proven effective but patient outcomes are variable. Here...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 63ed9d12-1ab8-5263-9606-6efa3859e5db
- DOI
- 10.1101/2020.06.11.144485
